When it comes to detecting macrosomia, ultrasound has its strengths and limitations. Two experts examine the research and offer practical advice.
When a 33-year-old we'll call Janet Freeman (G1, P0) presented at 38 weeks' gestation, we suspected that her fetus was larger than normal for her dates. Ultrasound indicated an estimated fetal weight of 4,000 g, at the 95th percentile. Her antepartum course was uncomplicated, except for a 1-hour glucose screening test, which was elevated at 140 mg/dL at 28 weeks' gestation, with subsequent normal 3-hour glucose tolerance test. How should this patient be counseled and managed?
Before answering that question, let's briefly review some of the basics, including
Defining fetal macrosomia
In 1996, about 10% of liveborn infants weighed more than 4,000 g, and 1.5% weighed more than 4,500 g.3,4 Given trends in obesity in the United States, it's surprising to find that the prevalence of macrosomia has actually decreased significantly since then. The prevalence of newborns weighing at least 4,000 g decreased by 10% from 1996 (10.2%) to 2002 (9.2%) and decreased by 19% for newborns with weights more than 5,000 g (from 0.16% to 0.13%, over the same time).4 This decline may be due to several factors, including routine testing for gestational diabetes, the increasing rates of multiple gestations, preterm deliveries, earlier and more routine inductions, and scheduled repeat cesarean deliveries.
Reviewing the causes and complications
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More